LLMpediaThe first transparent, open encyclopedia generated by LLMs

peptide E

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: enkephalin Hop 4
Expansion Funnel Raw 60 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted60
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
peptide E
Namepeptide E

peptide E is an endogenous opioid peptide derived from the precursor protein proenkephalin A. It was first isolated from the bovine adrenal medulla and is found in various central nervous system and peripheral nervous system tissues. The peptide exhibits potent opioid receptor activity, primarily at the mu opioid receptor and delta opioid receptor, and is involved in modulating pain perception and stress responses.

Structure and properties

Peptide E is a 25-amino acid polypeptide with the sequence Tyr-Gly-Gly-Phe-Met-Arg-Arg-Val-Gly-Arg-Pro-Glu-Trp-Trp-Met-Asp-Tyr-Gln-Lys-Arg-Tyr-Gly-Gly-Phe-Leu. This sequence contains multiple canonical enkephalin sequences, including Met-enkephalin at its N-terminus and Leu-enkephalin at its C-terminus, linked by an extended intermediate segment. The presence of these opioid peptide motifs is critical for its receptor binding affinity. The peptide's structure includes several basic residues, such as arginine and lysine, which influence its solubility and interaction with cell membrane receptors. Its molecular weight is approximately 3000 daltons, and it is often studied using techniques like high-performance liquid chromatography and mass spectrometry.

Discovery and history

The peptide was first discovered in 1979 by a research team led by Avram Goldstein at the Addiction Research Foundation in Palo Alto. It was isolated during the purification of enkephalin-containing peptides from extracts of the bovine adrenal medulla, a rich source of neuropeptides. The discovery was part of a broader wave of research in the late 1970s that identified numerous endogenous opioid substances, following the earlier isolation of β-endorphin from the pituitary gland by Roger Guillemin and endorphin by Choh Hao Li. The characterization of peptide E helped elucidate the complex processing of the proenkephalin A gene product and its role in the endogenous opioid system.

Biological function and effects

Peptide E functions as a potent agonist at mu opioid receptor and delta opioid receptor subtypes within the endogenous opioid system. Its primary biological effects include the modulation of nociception, where it acts to raise the threshold for pain perception in regions such as the periaqueductal gray and spinal cord. The peptide also influences stress response pathways, often co-released with catecholamines from the adrenal gland during acute stress. Furthermore, it can affect gastrointestinal motility by acting on enteric nervous system neurons and has been implicated in the regulation of mood and reward circuitry, interacting with systems involving dopamine and the nucleus accumbens.

Clinical significance and research

Research into peptide E has explored its potential role in pain management and addiction medicine, given its high potency and endogenous origin. Studies using animal models, such as the tail-flick test in Sprague-Dawley rats, have demonstrated its analgesic efficacy. Its involvement in stress-induced analgesia has made it a subject of interest for understanding conditions like post-traumatic stress disorder. However, its clinical application is limited by challenges in blood-brain barrier penetration and enzymatic degradation by peptidases like neprilysin. Investigations continue into stable analogs and delivery systems, with some research conducted at institutions like the National Institute on Drug Abuse.

Peptide E is a product of the proenkephalin A precursor, which also gives rise to several other biologically active opioid peptides through proteolytic cleavage. Key related peptides include Met-enkephalin, Leu-enkephalin, peptide F, and adrenorphin. It shares structural homology with peptides from the prodynorphin family, such as dynorphin A, and the proopiomelanocortin family, which yields β-endorphin. The study of these peptides collectively advanced the understanding of the endogenous opioid system by researchers like Huda Akil and Stanley Watson at the University of Michigan.

Category:Peptides Category:Opioid peptides Category:Neuropeptides